Abstract
Head and neck cancer (HNC) is a devastating disease that affects some of the most basic daily functions such as breathing, speaking, and swallowing. Because of its visible nature, HNC is also associated with significant disfigurement. The combined effect of disability and disfigurement and the added toxicity of treatment greatly increase symptom burden and reduce physical, emotional, and social functioning. Since its inception, the Head and Neck Oncology Program at MD Anderson Cancer Center has pioneered multidisciplinary care with the main goal of improving survival and reducing suffering in patients with HNC. Over the past 60 years, significant advances have been made in the treatment and rehabilitation of patients with HNC, resulting in improved disease control, survival, and organ preservation. The purpose of this chapter is to highlight some of the advances in treatment and improvements in outcome of patients with HNC treated in the Head and Neck Multidisciplinary Care Center at MD Anderson.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Siegel R, Ward E, Brawley O, Jemal A. The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212–36.
Cognetti DM, Weber RS, Lai SY. Head and neck cancer. Cancer. 2008;113(S7):1911–32.
Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35.
Sturgis EM, Dahlstrom KR. HPV vaccination. Inaccurate assumptions about oropharyngeal cancer. BMJ. 2009;339:b4525.
Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 1972;29(6):1446–9.
Moreno MA, Skoracki RJ, Hanna EY, Hanasono MM. Microvascular free flap reconstruction versus palatal obturation for maxillectomy defects. Head Neck. 2010;32(7):860–8.
Yu P, Clayman GL, Walsh GL. Long-term outcomes of microsurgical reconstruction for large tracheal defects. Cancer. 2011;117(4):802–8.
Hanna E, DeMonte F, Ibrahim S, Roberts D, Levine N, Kupferman M. Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results. Arch Otolaryngol Head Neck Surg. 2009;135(12):1219–24.
Holsinger FC, Nussenbaum B, Nakayama M, et al. Current concepts and new horizons in conservation laryngeal surgery: an important part of multidisciplinary care. Head Neck. 2010;32(5):656–65.
Laccourreye L, Garcia D, Ménard M, Brasnu D, Laccourreye O, Holsinger FC. Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula. Head Neck. 2008;30(6):756–64.
Laccourreye O, Seccia V, Ménard M, Garcia D, Vacher C, Holsinger FC. Extended lateral pharyngotomy for selected squamous cell carcinomas of the lateral tongue base. Ann Otol Rhinol Laryngol. 2009;118(6):428–34.
Lewis CM, Chung WY, Holsinger FC. Feasibility and surgical approach of transaxillary robotic thyroidectomy without CO2 insufflation. Head Neck. 2010;32(1):121–6.
Kupferman M, DeMonte F, Holsinger FC, Hanna E. Transantral robotic access to the pituitary gland. J Otolaryngol Head Neck Surg. 2009;141(3):413–5.
Hong WK, Shapshay SM, Bhutani R, et al. Induction chemotherapy in advanced squamous head and neck carcinoma with high-dose cis-platinum and bleomycin infusion. Cancer. 1979;44(1):19–25.
Hong WK, O’Donoghue GM, Sheetz S, et al. Sequential response patterns to chemotherapy and radiotherapy in head and neck cancer: potential impact of treatment in advanced laryngeal cancer. Prog Clin Biol Res. 1985;201:191–7.
Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324(24):1685–90.
Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091–8.
Milas L, Mason K, Hunter N, et al. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. Clin Cancer Res. 2000;6(2):701–8.
Ang KK, Berkey BA, Tu X, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res. 2002;62(24):7350–6.
Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354(6):567–78.
Kies MS, Holsinger FC, Lee JJ, et al. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol. 2010;28(1):8–14.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hanna, E., Glisson, B., Ang, K., Weber, R. (2013). Head and Neck Cancer. In: Rodriguez, M., Walters, R., Burke, T. (eds) 60 Years of Survival Outcomes at The University of Texas MD Anderson Cancer Center. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5197-6_25
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5197-6_25
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5196-9
Online ISBN: 978-1-4614-5197-6
eBook Packages: MedicineMedicine (R0)